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Original Article

Perioperative Glycemic Control and its Outcome in Patients following
Open Heart Surgery
Abstract

Background: Diabetes is not uncommon in patients requiring cardiac surgery. These patients
have a higher incidence of morbidity and mortality. Subsequently, diabetes represents a major
medico‑economic problem in both developed and developing countries. This study was designed to
observe the association between glycemic control and outcome of patients after open heart surgery
in adult population. Materials and Methods: Data was collected retrospectively in all patients who
underwent open cardiac surgery (coronary artery bypass grafting, valve, or bypass grafting with valve
surgery) and survived 72 hours postoperatively and had diabetes. The study was conducted from
January 2015 to December 2016. Results: Of the 129 patients included in the study, male dominated
101 (78.3%). Most frequent surgery was coronary artery bypass grafting (CABG) 123 (95.3%),
CABG plus aortic valve replacement 4 (3.1%), and CABG plus mitral valve replacement 2 (1.6%).
Considering diabetes, only 3 (2.3%) were on diet control, 112 (86.8%) on oral hypoglycemic
agents (OHA), whereas 9 (7%) had control on both insulin and OHA. Only 5 (3.9%) had
type I diabetes. The mean fasting blood sugar (FBS) was 154.58 g/dl, and the mean duration of
diabetic mellitus was observed 12.32 years. Microvascular and macrovascular complications were
26/129 (20.16%) and 17/129 (13.17%), respectively. Total 75 (58.1%) patients did not require
insulin and 54 (41.9%) were treated with insulin intraoperatively to keep the blood glucose level less
than 200 g/dl. Cardiac arrhythmias were frequent in the insulin group (P < 0.05), which was also
associated with increased stay in the cardiac intensive care unit. Conclusion: Inadequate glycemic
control during open cardiac surgery can possibly lead to increased perioperative morbidity and
mortality and with decreased long‑term survival and recurrent ischemic events. Therefore, aiming
for blood glucose levels around 140 mg/dl appears reasonable. Further studies are required to define
specific glucose ranges for a clearer definition of recommended blood glucose goals in postoperative
cardiac patients for the best outcomes in patients with diabetes mellitus.
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Introduction
It is estimated that approximately
30–40% of patients for coronary artery
bypass graft surgery (CABG) have
diabetes mellitus or impaired glucose
tolerance.[1,2] These patients present higher
incidence of morbidity and mortality and
increased length of hospital stay.[3,4]
Adequate
glycemic
control
in
perioperative period is essential for
improving the outcome in surgical
patients, especially those undergoing
CABG.[5] However, the uncertainty
still remains in the appropriate level of
perioperative glycemic control needed
to achieve the best possible outcome.
Some researchers advocate tight glycemic
This is an open access journal, and articles are
distributed under the terms of the Creative Commons
Attribution‑NonCommercial‑ShareAlike 4.0 License, which allows
others to remix, tweak, and build upon the work non‑commercially,
as long as appropriate credit is given and the new creations are
licensed under the identical terms.
For reprints contact: reprints@medknow.com

260

control (blood glucose 80–110 mg/dl) to
improve outcome and decreased wound
infections.[6,7] Whereas others reported no
improvement in morbidity and mortality
with the tight control and even suggest
possibilities of some adverse effects in
such patients.[8]
As a consequence of these conflicting data
and some recent research,[9] the Institute
for Healthcare Improvement and Society
of thoracic surgeons guidelines[10‑12]
recommend keeping blood glucose levels
to less than 180 mg/dl both intraoperatively
and during the ICU stay.
The objective of this study was to
observe
the
association
between
perioperative glycemic control and the
outcome of patients following open heart
surgery.
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Materials and Methods
This was a retrospective cohort study and was exempted by
the Ethical Review Committee of Aga Khan University
for informed consent. Patients having diabetes who were
admitted for open heart surgery in the last 2 years from
January 2015 to December 2016 with survival for at least
72 h were enrolled in this study.
Patients with diabetes mellitus either on diet control,
insulin dependent or noninsulin dependent before open
heart surgery (CABG, valves replacement and bypass
grafting with valve surgery) were included in the study.
Patients with nondiabetic, poor glycemic control, having
emergency surgery, having surgery with off‑pump
bypass, age less than 18 years, on dialysis, and having a
history of cerebral vascular accident/transient ischemic
attack (CVA/TIA) within the last six months were excluded
from the study.
For all patients included in the study, medical record (MR)
numbers were obtained, files were retrieved from medical
records, and data were collected on a predesigned data
collecting form by one of the investigators.
All statistical analyses was performed using Statistical
Packages for Social Science version 19 (SPSS Inc.,
Chicago, IL, USA). Mean and standard deviation were
computed for quantitative observation and analyzed
by independent sample t‑test whereas proportion and
percentage were computed for complication according to
the level of blood glucose and analyzed by Chi‑square test.
P ≤ 0.05 was considered significant.

Results
A total of 129 patients were observed in the study over the
period of 2 years. Demographic features, surgical variables,
and disease measures for all 129 patients are outlined in
Table 1. There were 101 (78.3%) males and 28 (21.7%)
females. Most frequent surgery was CABG alone
123 (95.3%), CABG plus aortic valve replacement (AVR)
4 (3.1%), and CABG plus mitral valve replacement (MVR)
2 (1.6%). The control of diabetes mellitus (on diet
control, insulin alone, or combination of insulin with oral
hypoglycemic agents [OHA]) was also observed. Only
3 (2.3%) had diet control diabetes, 112 (86.8%) had diabetes
control with oral hypoglycemic agents (OHA), 9 (7%) had
diabetes control through insulin with OHA, and 5 (3.9%)
had controlled it with insulin alone. The mean fasting blood
sugar (FBS) was 154.58 ± 55.56 g/dl and the mean duration
of diabetic mellitus was 12.32 ± 5.49 years. Recurrent
hypoglycemia was observed only in one female patient
preoperatively who had diet control diabetes. No intra and
postoperative complications were found in that patient.
Further, prior history of both macro and microvascular
complications related to DM were also observed.
Microvascular
complications
were
detected
in

26/129 (20.16%) and macrovascular complications were
detected in 17/129 (13.17%). Microvascular complications
were categorized as retinopathy, neuropathy, and
nephropathy, whereas macrovascular complications were
categorized as prior myocardial infarction (MI), prior
congestive heart failure (CHF), and peripheral vascular
disease (PVD) [Table 2].
Assessments were done related to the methods to control
diabetes during the intraoperative phase and blood
glucose levels, both intra and postoperatively [Table 3].
It was found that 75 (58.1%) patients did not require
Table 1: Demographic, surgery and diabetic measure of
the patients [n=129]

Variables
Age (years)
Weight (kg)
Height (cm)
BMI (km/m2)
Gender *

Point estimates
61.2±8.71 [35-85]
72.99±6.81 [55-89]
166.29±5.51 [152-178]
26.39±2.10 [22.03-33.76]

Male

101 (78.3%)

Female
Surgery*

28 (21.7%)

CABG

123 (95.3%)

CABG + AVR

4 (3.1%)

CABG + MVR
Diabetes control*

2 (1.6%)

Insulin + OHA

9 (7%)

Insulin

5 (3.9%)

Oral hypoglycemic agents

112 (86.8%)

Diet
3 (2.3%)
Fasting blood sugar (FBS)
154.58±55.56 [80-418]
Duration of diabetic mellitus
12.32±5.49 Years [0.5-25]
Recurrent Hypoglycemia*
1 (0.8%)
Results are presented as mean±SD, [min‑max] and *n (%)

Table 2: History of diabetic mellitus
complication (n=129)

Complications
Frequency Percentage
Microvascular Complication
26/129
20.16%
Retinopathy
5
19.2%
Neuropathy
7
26.9%
Nephropathy
4
15.4%
Retinopathy + Neuropathy
2
7.7%
Retinopathy + Nephropathy
3
11.5%
Neuropathy + Nephropathy
2
7.7%
Retinopathy + Neuropathy + Neuropathy
3
11.5%
Macrovascular Complication
17/129
13.17%
Prior MI
9
52.9%
Prior CHF
2
11.8%
PVD
4
23.5%
Prior MI + CHF + PVD
2
11.8%
Percentages of sub‑complications were computed by micro and
macro individually
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insulin intraoperatively, and 54 (41.9%) patients were
managed by bolus insulin   during the intraoperative
phase; the frequency of bolus dose was also monitored.
The average dose of insulin was 13.1 IU. In patients who
received insulin intra‑operatively, average blood glucose
level was 243.6 g/dl. The threshold to use insulin
bolus was blood sugar more than 180 g/dl. In addition,
102 patients needed insulin boluses on day one, 91 on
day two, and 81 on day three after the surgery.
Patients were followed postoperatively despite patients’
glucose managed with or without insulin and monitored
for any postoperative complication. Cardiac arrhythmias,
renal failure, ventilator support >24 hours, and length of
stay >3 were statistically significant among patients having
insulin for targeted glycemic control (<200 g/dl) in cardiac
intensive care unit (CICU) [Table 4].
Table 3: Intraoperative control on DM (n=129)

Variables
Intraoperative
No insulin
Bolus Insulin
Frequency use of insulin

Point estimates
75 (58.1%)
54 (41.9%)

1

20 (15.5%)

2

23 (17.8%)

3

10 (7.8%)

4
01 (0.8%)
13.140±8.01 [4‑36]
Average dose of insulin (IV) (n=54)
Level of Blood Glucose (>180 gm/dl)
243.69±43.91 [189‑448]
Intraoperative (n=54)
Postoperative
234.62±47.40[184‑452]
Day 1 (n=102, 79.1%)
231.14±45.56[181‑414]
Day 2 (n=91, 70.5%)
232.26±43.92[181‑383.5]
Day 3 (n=81, 62.8%)
Results are presented as mean±SD, [min‑max] and *n (%)

Table 4: Intraoperative control of blood sugar and
postoperative complication in CICU (n=129)
Complication

Intraoperative
P
Treatment
No Insulin Insulin
(n=75)
(n=54)
20 (26.7%) 25 (46.3%) 0.021
5 (6.7%) 12 (22.2%) 0.01*
0
0
NA
2 (2.7%)
0 (0%)
0.509
2 (2.7%)
1 (1.9%)
0.762
5 (6.7%) 12 (22.2%) 0.016
8 (10.7%) 17 (31.5%) 0.003*
0
0
NA

Renal failure
Cardiac arrhythmias
Myocardial infarction
Deep sternal infection
Multisystem failure
ventilator support >24 hours
Length of stay >3 days
Early mortality
(CICU or within 30 days)
Length prolonged Mechanical
5 (6.7%)
7 (13%)
0.225
ventilation
Results are presented as n (%) and mean±SD, [min‑max].Complication
in CICU was observed in 61 (47.3%) patients
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Discussion
Perioperative blood glucose control and administration of
insulin during open heart surgery in diabetic patients is
expected to have beneficial effects on patients’ outcome.
Administration of insulin will increase glucose uptake by
myocytes, promoting glycogenesis, and reducing free fatty
acids, while protecting heart against ischemia provided by
cardiopulmonary bypass.[13] Furthermore, hyperglycemia
has a pro‑inflammatory effect that may contribute to
postoperative capillary leak syndrome, platelet dysfunction,
and altered immune response that could be avoided by
blood glucose control.[14]
By revision of studies conducted on the effect of tight
glycemic control of diabetic patients on patients’ outcome
after CABG surgery, there was no fixed blood glucose
range taken as a single reference in these studies. The
definition of tight glycemic control was different and the
method by which one can achieve it was also varied. To
date, it remains unclear how tight the glycemic control
should be. For safety, in our study, the recommendations
of American Association of Clinical Endocrinologists
and American Diabetes Association (ADA/AACE) were
followed to define tight glycemic control to be between
110 and 149 mg/dl and moderate glycemic control to be
between 150 and 180 mg/dl.[12]
In 2009, normoglycemia in Intensive Care Evaluation‑Survival
Using Glucose Algorithm Regulation (NICE‑SUGAR) trial
made much change in concept of tight glycemic control as
they found that intensive glucose control (81–108 mg/dl)
actually increased 90‑day mortality with more episodes of
hypoglycemia recommending more liberal control of blood
glucose level.[15]
Numerous studies have now shown that patients
with acute coronary syndromes (ACS) who present
with hyperglycemia are at a higher risk of death
and
in‑hospital
complications.[16‑18]
Capes
and
[19]
co‑workers in meta‑analysis of 15 studies showed that
the risk of in‑hospital death in nondiabetic patients with
ACS and the admission glucose >110 mg/dl was 3.9 times
greater than in patients who were normoglycemic.
Desai et al.[20] found in a study on isolated CABG patients
that liberal blood glucose control between 121 and
180 mg/dl have better outcome in relation to blood glucose
control and target range needed and similar outcome to
tight glycemic control regarding morbidity and mortality.
Girish et al.[21] also supported in their review that it
is sensible to maintain blood sugar level between a
safe intermediate range of 140–180 mg/dl or better
still <150 mg/dl keeping in view the potentially dangerous
consequences of hypoglycemia and hyperglycemia.
The relationship between tight glycemic control and
decreased surgical wound infection was addressed first
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in 1991 when the American College of Cardiology and
American Heart Association noted increased incidence of
wound infection in diabetic patients.[22]
A cohort study by Estrada et al.[23] of 1574 patients who
had undergone coronary artery bypass grafting assessed
for 30 days for mortality, infection rates (sternum, harvest
site, sepsis, pneumonia, urinary tract), and the utilization
of resources found no statistical significant relationship
between surgical site infection and blood glucose level
between diabetic and nondiabetic groups.
Arrhythmias following cardiac surgery are common
affecting up to 20–30% of patients.[24] The mechanisms
by which atrial fibrillation can occur after cardiac
surgery is unclear, but certain theories such as cooling of
atrium, increased sympathetic activity, and withdrawal of
preoperative B‑blockers are acknowledged on animal and
human trials.[25,26] All the previous factors could contribute
to change in refractory period in the atrium predisposing to
atrial fibrillation.[27] In our study, a significant reduction in
arrhythmias was found in group which was not on insulin.
This is a unique finding in this study but other studies also
support tight glycemic with better arrhythmias control in
this regard.[6,28]
Length of CICU stay was also relatively high in patients
who received insulin to manage glycemic control
intraoperatively compared with those who did not receive
insulin for glycemic control. These findings were also
contradictory to other studies which showed a significant
reduction in the amount of time spent on ventilation for
patients who had tight glycemic control. However, there
was also significant heterogeneity in the data.[6,29] On the
contrary, another study stated that hypoglycemia with
thorough insulin therapy is independently associated with
increased risk for respiratory complications and prolonged
hospital and intensive care unit length of stay after cardiac
surgery.[30]

in postoperative cardiac patients, resulting in the best
outcomes and least incidence of hypoglycemia. Therefore,
more studies are recommended with greater sample size
and longer follow‑up duration to confirm the results with
CAD being included in macrovascular complication, as that
was one of the limitation of this study.

Conclusion
Hypo or hyperglycemia during open cardiac surgery can
possibly lead to increased perioperative morbidity and
mortality and can be associated with decreased long‑term
survival and recurring ischemic events. Therefore, aiming
for blood glucose levels around 140 mg/dl appears
reasonable; however, the exact range is still not clearly
defined. Further studies are required to define specific
glucose ranges for a clearer definition of recommended
blood glucose goals in postoperative cardiac patients for
the best outcomes in patients with diabetes mellitus.
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